MOLN compared with BNTC: revenue, margins and what each company keeps, and the suppliers and customers both name

MOLNMolecular Partners AG

Mkt capRevenueRevenue

BNTCBenitec Biopharma Inc.

Mkt capRevenueRevenue

Compare

MOLNMolecular Partners AG

BNTCBenitec Biopharma Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MOLN1 of 4 reports

Reportimpliedrealized× implied

Oct 29 '26—▼−4.88%—

BNTC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Sep 15 '26±33.9%▼−8.53%×0.25

Q3 FY26±46.8%▲+1.72%×0.04

= impliedMOLN realized, solidBNTC realized, hatchedOne scale, both sides: full bar = 47%× = |realized| ÷ impliedSource: market data

Feb 12 '26

±42.4%

▼−2.66%

×0.06

Nov 17 '25±33.2%▲+2.81%×0.08

MOLNMolecular Partners AG

3.98▲+23.79%· post 3.17

Mkt cap$129.8MRevenue—

BNTCBenitec Biopharma Inc.

9.41▲+8.91%· post 9.41

ClosedNov 6 '26

Mkt cap$332.8MRevenue$7,000Q4 FY23

Compare

ClosedNov 6 '26

MOLNMolecular Partners AG

BNTCBenitec Biopharma Inc.

3.98▲+23.79%post 3.17

Price

9.41▲+8.91%post 9.41

$129.8M

Mkt cap

$332.8M

—

Revenue

$7,000Q4 FY23

MOLN3.98▲+23.79%vsBNTC9.41▲+8.91%ClosedNov 6 '26